Literature DB >> 23563023

Effects of chronic flunitrazepam treatment schedule on therapy-induced sedation and motor impairment in mice.

Sylwia Talarek1, Jolanta Orzelska, Joanna Listos, Antonina Mazur, Sylwia Fidecka.   

Abstract

BACKGROUND: The aim of the present study was to examine whether different treatment schedules could be associated with tolerance development to the ataxic and sedative effects of flunitrazepam in mice.
METHODS: Effects of repeated flunitrazepam administration were studied in the rotarod and the chimney test for motor coordination and in a photocell apparatus for locomotor activity in mice. Flunitrazepam doses varied in particular types of injections or in different experiment duration periods.
RESULTS: Repeated flunitrazepam administration (1 mg/kg, sc and 2 mg/kg, ip) for 8 consecutive days induced tolerance to the motor impairing effects of flunitrazepam in mice, both in the rotarod and the chimney test. In turn, no tolerance developed to sedative flunitrazepam effects, regarding either dose level, injection type or treatment duration.
CONCLUSIONS: Those findings confirmed the previous observations that tolerance to benzodiazepines was not simultaneous for each pharmacological property of the drugs. Interestingly enough, an acute dose of flunitrazepam (1 mg/kg, sc) in our study enhanced locomotor activity of mice.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23563023     DOI: 10.1016/s1734-1140(13)70963-0

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  2 in total

1.  Central Effects of the Designer Drug Mephedrone in Mice-Basic Studies.

Authors:  Anna Serefko; Gabriela Bielecka-Papierz; Sylwia Talarek; Aleksandra Szopa; Piotr Skałecki; Bernadeta Szewczyk; Maria Radziwoń-Zaleska; Ewa Poleszak
Journal:  Brain Sci       Date:  2022-01-30

2.  The Importance of L-Arginine:NO:cGMP Pathway in Tolerance to Flunitrazepam in Mice.

Authors:  Sylwia Talarek; Joanna Listos; Jolanta Orzelska-Gorka; Malgorzata Jakobczuk; Jolanta Kotlinska; Grazyna Biala
Journal:  Neurotox Res       Date:  2016-12-12       Impact factor: 3.911

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.